Bruin Biometrics LLC is engaging and collaborating with healthcare professionals and industry thought leaders to explore how science and innovation advance healthcare through preventive solutions.
It is the purpose of Bruin Biometrics LLC to modernize care pathways through developing and collaboratively integrating new-to-the-world biometric-sensor based medical devices. Below are just a few of the preventative solutions Bruin Biometrics LLC is committed to.
Introducing ProvizioTM SEM Scanner, the first hand-held wireless scanner with intelligence inside, for fast and easy Pressure Injury/Ulcer (PI/PU) risk assessment and the only SEM Scanner that acts as an adjunct to routine clinical skin assessment. Digitally enhance the patient care pathway with built-in data transfer for enhanced insight and PI/PU risk identification, five days* earlier than visual skin assessment.1
In clinical practice since 2014, the new ProvizioTM SEM Scanner has, in preliminary laboratory testing, shown the same precision as the previous SEM Scanner 200 model.2
1. Okonkwo H. et al. (2020). A blinded clinical study using a subepidermal moisture biocapacitance device for early detection of pressure injuries. Wound Repair Regen, (online) 1-11. Available at: https://doi.org/10.1111/wrr.12790 (Accessed: 21 January 2020)
2. Peko, L. and Gefen, A. (2020), Sensitivity and laboratory performances of a second generation subepidermal moisture measurement device. Int Wound J. 1-4. doi:10.1111/iwj.13339
In the US, the demand for primary total hip arthroplasties (THA) and total knee arthroplasties (TKA) is estimated to grow to 600,000 and 3.5 million procedures a year respectively, by 20301. If the historical growth trajectory of joint replacement surgeries continues, demand for primary THA and TKA among patients less than 65 years old is projected to exceed 50% of THA and TKA patients of all ages2.
As a preventative solution, Bruin Biometrics LLC is in the process of developing OrthoSonos, an Acoustic Emission (AE) based joint health monitor for natural and artificial joints.
1. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89(4):780-785
2. Kurtz S, Lau E, Ong K, Zhao K, Kelly M, Bozic K. Future Young Patient Demand for Primary and Revision Joint Replacement: National Projections from 2010 to 2030. Clinical Orthopaedics and Related Research. 2009;467(10):2606-2612
Bruin Biometrics LLC has sponsored the development of a global Pressure Injury/Ulcer Registry. This Registry is the first of its kind in pressure injury/ulcer (PI/PU) to provide a global database and is an ambitious collaborative opportunity between Bruin Biometrics LLC, manufacturers of the ProvizioTM SEM Scanner, academics, researchers and tissue viability/wound care specialists all over the world. Its primary objective is to improve the quality of care delivered to patients at risk of developing PI/PUs. Bruin Biometrics LLC is committed to achieving full prevention of PI/PUs and understand that the right clinical strategy and allocation of resources is critical to achieving the goal of prevention.
Have questions about our company, products or pipeline? We'd like to hear from you.